Pathophysiology and natural based therapeutic strategies for psoriasis: Insights from promising clinical trials
DOI:
https://doi.org/10.52783/jns.v14.3528Keywords:
Autoimmune, Cytokines, Inflammation, Psoriasis, Phytochemicals, Psoriasis managementAbstract
Psoriasis is a long-term autoimmune inflammatory ailment with a multifaceted pathophysiology altered by genetic tendency, environmental triggers, and immune system abnormalities. It is marked by excessive keratinocyte growth, immune dysfunction, and increased oxidative stress, contributing to persistent inflammation. Conventional therapies, including corticosteroids, immunosuppressants, and biologics, have limitations due to adverse effects and long-term safety concerns. This review explores the pathogenesis of psoriasis, highlighting immune response mechanisms, oxidative stress involvement, and the potential of natural compounds as therapeutic alternatives. Medicinal plants, phytochemicals, and biologically active components such as flavonoids, polyphenols, and alkaloids have revealed promising anti-inflammatory and immunomodulatory effects. Clinical studies suggest that these natural agents can regulate cytokine production, inhibit keratinocyte proliferation, and modulate oxidative stress pathways, offering a safer and more profitable approach to psoriasis controlling. This review further explores the molecular interactions between plant-based bioactive agents and immune mechanisms, paving the way for novel natural therapeutic strategies
Downloads
Metrics
References
Samotij, D, B Nedoszytko, J Bartosińska, A Batycka-Baran, R Czajkowski, IT Dobrucki, . . . A Reich, Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances. Postepy Dermatol Alergol. 2020;37:2:135-153.
Rendon, A and K Schäkel, Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20:6.
Benhadou, F, D Mintoff, B Schnebert, and HB Thio, Psoriasis and Microbiota: A Systematic Review. Diseases. 2018;6:2.
Christophers, E, Psoriasis--epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:4:314-20.
Burch, PR and NR Rowell, Mode of inheritance in psoriasis. Arch Dermatol. 1981;117:5:251-2.
Smith, AE, JY Kassab, CM Rowland Payne, and WE Beer, Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology. 1993;186:3:181-6.
Ferrándiz, C, RM Pujol, V García-Patos, X Bordas, and JA Smandía, Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46:6:867-73.
Napolitano, M, F Caso, R Scarpa, M Megna, A Patrì, N Balato, and L Costa, Psoriatic arthritis and psoriasis: differential diagnosis. Clin Rheumatol. 2016;35:8:1893-1901.
Elkhawaga, OY, MM Ellety, SO Mofty, MS Ghanem, and AO Mohamed, Review of natural compounds for potential psoriasis treatment. Inflammopharmacology. 2023;31:3:1183-1198.
Zhou, X, Y Chen, L Cui, Y Shi, and C Guo, Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13:1:81.
Niehues, H, G Rikken, I van Vlijmen-Willems, D Rodijk-Olthuis, PEJ van Erp, P Zeeuwen, . . . EH van den Bogaard, Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis. JID Innov. 2022;2:1:100066.
Sugiyama, H, R Gyulai, E Toichi, E Garaczi, S Shimada, SR Stevens, . . . KD Cooper, Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol. 2005;174:1:164-73.
Zhou, X, JG Krueger, MC Kao, E Lee, F Du, A Menter, . . . AM Bowcock, Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics. 2003;13:1:69-78.
Serbina, NV, TP Salazar-Mather, CA Biron, WA Kuziel, and EG Pamer, TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 2003;19:1:59-70.
Liu, Y, S Cui, J Sun, X Yan, and D Han, Identification of Potential Biomarkers for Psoriasis by DNA Methylation and Gene Expression Datasets. Front Genet. 2021;12:722803.
Dopytalska, K, P Ciechanowicz, K Wiszniewski, E Szymańska, and I Walecka, The Role of Epigenetic Factors in Psoriasis. Int J Mol Sci. 2021;22:17.
Fahlén, A, L Engstrand, BS Baker, A Powles, and L Fry, Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304:1:15-22.
Henseler, T and E Christophers, Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:3:450-6.
Ayala, F, Clinical presentation of psoriasis. Reumatismo. 2007;59 Suppl 1:40-5.
Carvalho, AV, R Romiti, CD Souza, RS Paschoal, LM Milman, and LP Meneghello, Psoriasis comorbidities: complications and benefits of immunobiological treatment. An Bras Dermatol. 2016;91:6:781-789.
Krueger, JG, The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol. 2002;46:1:1-23; quiz 23-6.
Takeshita, J, S Grewal, SM Langan, NN Mehta, A Ogdie, AS Van Voorhees, and JM Gelfand, Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76:3:377-390.
Nestle, FO, C Conrad, A Tun-Kyi, B Homey, M Gombert, O Boyman, . . . M Gilliet, Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005;202:1:135-43.
Lew, W, AM Bowcock, and JG Krueger, Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol. 2004;25:6:295-305.
McKenzie, BS, RA Kastelein, and DJ Cua, Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006;27:1:17-23.
Nickoloff, BJ, B Bonish, BB Huang, and SA Porcelli, Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci. 2000;24:3:212-25.
Prinz, JC, B Gross, S Vollmer, P Trommler, I Strobel, M Meurer, and G Plewig, T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol. 1994;24:3:593-8.
Blumberg, H, H Dinh, ES Trueblood, J Pretorius, D Kugler, N Weng, . . . JJ Peschon, Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med. 2007;204:11:2603-14.
Macleod, T, JS Ainscough, C Hesse, S Konzok, A Braun, AL Buhl, . . . M Stacey, The Proinflammatory Cytokine IL-36γ Is a Global Discriminator of Harmless Microbes and Invasive Pathogens within Epithelial Tissues. Cell Rep. 2020;33:11:108515.
Green, S, A Dobrjansky, EA Carswell, RL Kassel, LJ Old, N Fiore, and MK Schwartz, Partial purification of a serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1976;73:2:381-5.
Finch, PW, F Murphy, I Cardinale, and JG Krueger, Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol. 1997;151:6:1619-28.
Lambert, AJ and MD Brand, Reactive oxygen species production by mitochondria. Methods Mol Biol. 2009;554:165-81.
Turrens, JF, Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:Pt 2:335-44.
Slimen, IB, T Najar, A Ghram, H Dabbebi, M Ben Mrad, and M Abdrabbah, Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia. 2014;30:7:513-23.
Brieger, K, S Schiavone, FJ Miller, Jr., and KH Krause, Reactive oxygen species: from health to disease. Swiss Med Wkly. 2012;142:w13659.
Richter, K and T Kietzmann, Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res. 2016;365:3:591-605.
Barygina, V, M Becatti, F Prignano, T Lotti, N Taddei, and C Fiorillo, Fibroblasts to Keratinocytes Redox Signaling: The Possible Role of ROS in Psoriatic Plaque Formation. Antioxidants (Basel). 2019;8:11.
Alderton, WK, CE Cooper, and RG Knowles, Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:Pt 3:593-615.
Zhou, Q, U Mrowietz, and M Rostami-Yazdi, Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med. 2009;47:7:891-905.
Kröncke, KD, K Fehsel, and V Kolb-Bachofen, Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe Seyler. 1995;376:6:327-43.
Oszukowska, M, M Kozłowska, and A Kaszuba, Paraoxonase-1 and other factors related to oxidative stress in psoriasis. Postepy Dermatol Alergol. 2020;37:1:92-96.
Pleńkowska, J, M Gabig-Cimińska, and P Mozolewski, Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis. Int J Mol Sci. 2020;21:17.
Gabr, SA and AH Al-Ghadir, Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res. 2012;304:6:451-7.
Kadam, DP, AN Suryakar, RD Ankush, CY Kadam, and KH Deshpande, Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25:4:388-92.
Shah, AA and AA Sinha, Oxidative stress and autoimmune skin disease. Eur J Dermatol. 2013;23:1:5-13.
Nemati, H, R Khodarahmi, M Sadeghi, A Ebrahimi, M Rezaei, and A Vaisi-Raygani, Antioxidant status in patients with psoriasis. Cell Biochem Funct. 2014;32:3:268-273.
Pujari, VM, S Ireddy, I Itagi, and HS Kumar, The serum levels of malondialdehyde, vitamin e and erythrocyte catalase activity in psoriasis patients. J Clin Diagn Res. 2014;8:11:Cc14-6.
Briganti, S and M Picardo, Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol. 2003;17:6:663-9.
Baek, JO, D Byamba, WH Wu, TG Kim, and MG Lee, Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress. Arch Dermatol Res. 2012;304:9:699-706.
Young, CN, JI Koepke, LJ Terlecky, MS Borkin, SL Boyd, and SR Terlecky, Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol. 2008;128:11:2606-2614.
Aksoy, M and A Kirmit, Thiol/disulphide balance in patients with psoriasis. Postepy Dermatol Alergol. 2020;37:1:52-55.
Magenta, A, E Dellambra, R Ciarapica, and MC Capogrossi, Oxidative stress, microRNAs and cytosolic calcium homeostasis. Cell Calcium. 2016;60:3:207-17.
Jain, S, IR Kaur, S Das, SN Bhattacharya, and A Singh, T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol. 2009;58:Pt 2:180-184.
Gostner, JM, K Becker, D Fuchs, and R Sucher, Redox regulation of the immune response. Redox Rep. 2013;18:3:88-94.
Campanati, A, G Goteri, O Simonetti, G Ganzetti, K Giuliodori, A Giuliano, . . . A Offidani, Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Int J Immunopathol Pharmacol. 2009;22:2:371-7.
Nofal, A, I Al-Makhzangy, E Attwa, A Nassar, and A Abdalmoati, Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control. J Eur Acad Dermatol Venereol. 2009;23:7:803-6.
Detmar, M, LF Brown, MP Schön, BM Elicker, P Velasco, L Richard, . . . RK Jain, Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998;111:1:1-6.
Takahashi, H, M Ibe, S Nakamura, A Ishida-Yamamoto, Y Hashimoto, and H Iizuka, Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci. 2002;30:2:94-9.
Johansen, C, K Kragballe, M Westergaard, J Henningsen, K Kristiansen, and L Iversen, The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol. 2005;152:1:37-42.
Fenini, G, S Grossi, S Gehrke, H-D Beer, TK Satoh, E Contassot, and LE French, The p38 Mitogen-Activated Protein Kinase Critically Regulates Human Keratinocyte Inflammasome Activation. Journal of Investigative Dermatology. 2018;138:6:1380-1390.
Carballo, M, M Conde, R El Bekay, J Martín-Nieto, MJ Camacho, J Monteseirín, . . . F Sobrino, Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem. 1999;274:25:17580-6.
Svendsen, MT, J Jeyabalan, KE Andersen, F Andersen, and H Johannessen, Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review. J Dermatolog Treat. 2017;28:5:374-383.
Farahnik, B, D Sharma, J Alban, and RK Sivamani, Topical Botanical Agents for the Treatment of Psoriasis: A Systematic Review. Am J Clin Dermatol. 2017;18:4:451-468.
Ricketts, JR, MJ Rothe, and JM Grant-Kels, Nutrition and psoriasis. Clinics in Dermatology. 2010;28:6:615-626.
Timoszuk, M, K Bielawska, and E Skrzydlewska, Evening Primrose (Oenothera biennis) Biological Activity Dependent on Chemical Composition. Antioxidants (Basel). 2018;7:8.
Ramadan, R, A Tawdy, R Abdel Hay, L Rashed, and D Tawfik, The antioxidant role of paraoxonase 1 and vitamin E in three autoimmune diseases. Skin Pharmacol Physiol. 2013;26:1:2-7.
Miroddi, M, M Navarra, F Calapai, F Mancari, SV Giofrè, S Gangemi, and G Calapai, Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis. Phytother Res. 2015;29:5:648-55.
Puangsricharoen, B, K Vanikieti, P Jindahra, and T Padungkiatsagul, Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study. Clin Ophthalmol. 2022;16:3381-3389.
Radha, MH and NP Laxmipriya, Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review. J Tradit Complement Med. 2015;5:1:21-6.
Leng, H, L Pu, L Xu, X Shi, J Ji, and K Chen, Effects of aloe polysaccharide, a polysaccharide extracted from Aloe vera, on TNF α induced HaCaT cell proliferation and the underlying mechanism in psoriasis. Mol Med Rep. 2018;18:3:3537-3543.
Richard, EG, The Science and (Lost) Art of Psoralen Plus UVA Phototherapy. Dermatol Clin. 2020;38:1:11-23.
Sivanesan, SP, S Gattu, J Hong, A Chavez-Frazier, GD Bandow, F Malick, . . . J Koo, Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks. J Am Acad Dermatol. 2009;61:5:793-8.
Ha, H, H Lee, CS Seo, HS Lim, JK Lee, MY Lee, and H Shin, Artemisia capillaris inhibits atopic dermatitis-like skin lesions in Dermatophagoides farinae-sensitized Nc/Nga mice. BMC Complement Altern Med. 2014;14:100.
Lee, SY, S Nam, IK Hong, H Kim, H Yang, and HJ Cho, Antiproliferation of keratinocytes and alleviation of psoriasis by the ethanol extract of Artemisia capillaris. Phytother Res. 2018;32:5:923-932.
Lee, SY, S Nam, S Kim, JS Koo, IK Hong, H Kim, . . . HJ Cho, Therapeutic Efficacies of Artemisia capillaris Extract Cream Formulation in Imiquimod-Induced Psoriasis Models. Evid Based Complement Alternat Med. 2018;2018:3610494.
Liu, CL, L Cheng, CH Ko, CW Wong, WH Cheng, DW Cheung, . . . C Bik-San Lau, Bioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway. J Ethnopharmacol. 2012;143:3:867-75.
Baek, GH, YS Jang, SI Jeong, J Cha, M Joo, SW Shin, . . . HS Jeong, Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products. Inflammation. 2012;35:4:1232-41.
Jia, J, X Mo, J Liu, F Yan, N Wang, Y Lin, . . . D Chen, Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis. Eur J Pharmacol. 2020;868:172881.
Tang, L, S He, X Wang, H Liu, Y Zhu, B Feng, . . . G Zheng, Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3. Exp Dermatol. 2018;27:3:268-275.
Henrich, F, W Magerl, T Klein, W Greffrath, and RD Treede, Capsaicin-sensitive C- and A-fibre nociceptors control long-term potentiation-like pain amplification in humans. Brain. 2015;138:Pt 9:2505-20.
Agrawal, U, M Gupta, and SP Vyas, Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 2015;43:1:33-9.
Manach, C, A Scalbert, C Morand, C Rémésy, and L Jiménez, Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79:5:727-47.
Deng, S, BH May, AL Zhang, C Lu, and CC Xue, Phytotherapy in the management of psoriasis: a review of the efficacy and safety of oral interventions and the pharmacological actions of the main plants. Arch Dermatol Res. 2014;306:3:211-29.
Chen, Y, S Song, Y Wang, J Zhu, and X Li, Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17/IL-17 axis by activating PPARγ. Phytother Res. 2022;36:10:3969-3987.
Wang, P-W, T-Y Lin, P-M Yang, J-Y Fang, W-T Li, and T-L Pan, Therapeutic efficacy of Scutellaria baicalensis Georgi against psoriasis-like lesions via regulating the responses of keratinocyte and macrophage. Biomedicine & Pharmacotherapy. 2022;155:113798.
Chamcheu, JC, S Esnault, VM Adhami, AL Noll, S Banang-Mbeumi, T Roy, . . . H Mukhtar, Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 2019;8:9.
Li, W, L Qin, R Feng, G Hu, H Sun, Y He, and R Zhang, Emerging senolytic agents derived from natural products. Mechanisms of Ageing and Development. 2019;181:1-6.
Ma, YC, A Mani, Y Cai, J Thomson, J Ma, F Peudru, . . . ZT Shi, An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products. Phytomedicine. 2016;23:4:377-87.
Opiyo, SA, PW Njoroge, EG Ndirangu, and KM Kuria, A review of biological activities and phytochemistry of Rhus species. 2021.
Koyu, H and MZ Haznedaroglu, Investigation of impact of storage conditions on Hypericum perforatum L. dried total extract. J Food Drug Anal. 2015;23:3:545-551.
Xiong, H, Y Xu, G Tan, Y Han, Z Tang, W Xu, . . . Q Guo, Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells. Cell Physiol Biochem. 2015;35:4:1335-46.
Kiekow, CJ, F Figueiró, F Dietrich, LD Vechia, EN Pires, EH Jandrey, . . . G Gosmann, Quercetin derivative induces cell death in glioma cells by modulating NF-κB nuclear translocation and caspase-3 activation. Eur J Pharm Sci. 2016;84:116-22.
Chen, H, C Lu, H Liu, M Wang, H Zhao, Y Yan, and L Han, Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Int Immunopharmacol. 2017;48:110-117.
Ross, JA and CM Kasum, Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22:19-34.
Mirzoeva, S, X Tong, BB Bridgeman, MP Plebanek, and OV Volpert, Apigenin Inhibits UVB-Induced Skin Carcinogenesis: The Role of Thrombospondin-1 as an Anti-Inflammatory Factor. Neoplasia. 2018;20:9:930-942.
Singh, VK, D Sahoo, K Agrahari, A Khan, P Mukhopadhyay, D Chanda, and NP Yadav, Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB/c mice. Life Sci. 2023;328:121909.
Li, Y, H Cui, S Li, X Li, H Guo, KS Nandakumar, and Z Li, Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions. Int Immunopharmacol. 2023;114:109585.
Liu, C, H Liu, C Lu, J Deng, Y Yan, H Chen, . . . Z Dai, Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin Exp Immunol. 2019;198:3:403-415.
Calabrese, EJ, G Dhawan, R Kapoor, E Agathokleous, and V Calabrese, Hormesis: Wound healing and keratinocytes. Pharmacological Research. 2022;183:106393.
Xue, JC, S Yuan, H Meng, XT Hou, J Li, HM Zhang, . . . QG Zhang, The role and mechanism of flavonoid herbal natural products in ulcerative colitis. Biomed Pharmacother. 2023;158:114086.
Duan, X, Y Li, F Xu, and H Ding, Study on the neuroprotective effects of Genistein on Alzheimer's disease. Brain Behav. 2021;11:5:e02100.
Polkowski, K and AP Mazurek, Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm. 2000;57:2:135-55.
Wang, A, J Wei, C Lu, H Chen, X Zhong, Y Lu, . . . L Han, Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes. Int Immunopharmacol. 2019;69:270-278.
, E, M Moskot, J Jakóbkiewicz-Banecka, G Węgrzyn, B Banecki, A Szczerkowska-Dobosz, . . . M Gabig-Cimińska, Molecular action of isoflavone genistein in the human epithelial cell line HaCaT. PLoS One. 2018;13:2:e0192297.
Winiarska-Mieczan, A, T Mieczan, and G Wójcik, Importance of Redox Equilibrium in the Pathogenesis of Psoriasis-Impact of Antioxidant-Rich Diet. Nutrients. 2020;12:6.
Zhang, S, X Liu, L Mei, H Wang, and F Fang, Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:1:334.
Khatoon, K, A Ali, FJ Ahmad, Z Hafeez, MMA Rizvi, S Akhter, and S Beg, Novel nanoemulsion gel containing triple natural bio-actives combination of curcumin, thymoquinone, and resveratrol improves psoriasis therapy: in vitro and in vivo studies. Drug Deliv Transl Res. 2021;11:3:1245-1260.
Lai, CY, YW Su, KI Lin, LC Hsu, and TH Chuang, Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation. J Immunol Res. 2017;2017:7807313.
Oliveira, ALB, VVS Monteiro, KC Navegantes-Lima, JF Reis, RS Gomes, DVS Rodrigues, . . . MC Monteiro, Resveratrol Role in Autoimmune Disease-A Mini-Review. Nutrients. 2017;9:12.
Shehzad, A, F Wahid, and YS Lee, Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010;343:9:489-99.
Kurd, SK, N Smith, A VanVoorhees, AB Troxel, V Badmaev, JT Seykora, and JM Gelfand, Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. J Am Acad Dermatol. 2008;58:4:625-31.
Tu, CT, B Han, QY Yao, YA Zhang, HC Liu, and SC Zhang, Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. Int Immunopharmacol. 2012;12:1:151-7.
Cho, JW, KS Lee, and CW Kim, Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med. 2007;19:3:469-74.
Sun, J, J Han, Y Zhao, Q Zhu, and J Hu, Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells. Int Immunopharmacol. 2012;13:2:170-4.
Torricelli, C, V Fortino, E Capurro, G Valacchi, A Pacini, M Muscettola, . . . E Maioli, Rottlerin inhibits the nuclear factor kappaB/cyclin-D1 cascade in MCF-7 breast cancer cells. Life Sci. 2008;82:11-12:638-43.
Putic, A, L Stecher, H Prinz, and K Müller, Structure-activity relationship studies of acridones as potential antipsoriatic agents. 1. Synthesis and antiproliferative activity of simple N-unsubstituted 10H-acridin-9-ones against human keratinocyte growth. Eur J Med Chem. 2010;45:8:3299-310.
Min, M, BX Yan, P Wang, L Landeck, JQ Chen, W Li, . . . XY Man, Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies. PLoS One. 2017;12:12:e0190051.
Clinton, SK, Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev. 1998;56:2 Pt 1:35-51.
Mangels, AR, JM Holden, GR Beecher, MR Forman, and E Lanza, Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc. 1993;93:3:284-96.
Trejo-Solís, C, J Pedraza-Chaverrí, M Torres-Ramos, D Jiménez-Farfán, A Cruz Salgado, N Serrano-García, . . . J Sotelo, Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition. Evid Based Complement Alternat Med. 2013;2013:705121.
Shih, CM, CK Hsieh, CY Huang, CY Huang, KH Wang, TH Fong, . . . AW Lee, Lycopene Inhibit IMQ-Induced Psoriasis-Like Inflammation by Inhibiting ICAM-1 Production in Mice. Polymers (Basel). 2020;12:7.
Dong, X, J Fu, X Yin, S Cao, X Li, L Lin, and J Ni, Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics. Phytother Res. 2016;30:8:1207-18.
Nguyen, UT, LTH Nguyen, BA Kim, MJ Choi, IJ Yang, and HM Shin, Natural Compound Mixture, Containing Emodin, Genipin, Chlorogenic Acid, Cimigenoside, and Ginsenoside Rb1, Ameliorates Psoriasis-Like Skin Lesions by Suppressing Inflammation and Proliferation in Keratinocytes. Evid Based Complement Alternat Med. 2020;2020:9416962.
Maleš, Ž, DL Drvar, I Duka, and K Žužul, Application of medicinal plants in several dermatovenerological entities. Acta Pharm. 2019;69:4:525-531.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
